Amy D. Robertson
Assistant Professor
Also affiliated: University of Kansas (2020–2022); University of Mississippi Medical Center (2014); Sisters of Mercy Health System (2018)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Amy D. Robertson's research focuses on pharmacy education and practice, with a particular emphasis on student learning and patient care. She has investigated the implementation and evaluation of simulation-based learning activities designed to enhance pharmacy students' empathy and communication skills, particularly concerning at-risk opioid behaviors in community pharmacy settings. Her work also examines practical aspects of pharmacy operations, including the impact of automated notifications on prescription abandonment and the knowledge and understanding of medication synchronization programs among pharmacy staff. Robertson has also explored clinical topics, such as the incidence of acute kidney injury in patients receiving specific antibiotic combinations and pain assessment strategies for elderly patients. Her scholarship metrics include an h-index of 5, with 12 publications and 103 citations.
Metrics
- h-index: 4
- Publications: 11
- Citations: 94
Positions
-
Assistant Professor publications 2018–2023University of Arkansas for Medical Sciences Institution web page
Selected Publications
-
Identifying Opportunities for Impact of Community-Based Pharmacist-Led Biometric Health Screenings on ASCVD Risk (2023)
-
Pilot Evaluation of Pharmacists’ and Pharmacy Technicians’ Knowledge and Understanding of a Medication Synchronization Program (2021)
-
Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin‐Tazobactam or Meropenem (2018)
Collaboration Network
Top Collaborators
- Pilot Evaluation of Pharmacists’ and Pharmacy Technicians’ Knowledge and Understanding of a Medication Synchronization Program
- Identifying Opportunities for Impact of Community-Based Pharmacist-Led Biometric Health Screenings on ASCVD Risk
- Pilot Evaluation of Pharmacists’ and Pharmacy Technicians’ Knowledge and Understanding of a Medication Synchronization Program
- Identifying Opportunities for Impact of Community-Based Pharmacist-Led Biometric Health Screenings on ASCVD Risk
- Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin‐Tazobactam or Meropenem
- Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin‐Tazobactam or Meropenem
- Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin‐Tazobactam or Meropenem
- Pilot Evaluation of Pharmacists’ and Pharmacy Technicians’ Knowledge and Understanding of a Medication Synchronization Program
- Pilot Evaluation of Pharmacists’ and Pharmacy Technicians’ Knowledge and Understanding of a Medication Synchronization Program
- Identifying Opportunities for Impact of Community-Based Pharmacist-Led Biometric Health Screenings on ASCVD Risk
- Identifying Opportunities for Impact of Community-Based Pharmacist-Led Biometric Health Screenings on ASCVD Risk
- Identifying Opportunities for Impact of Community-Based Pharmacist-Led Biometric Health Screenings on ASCVD Risk
- Identifying Opportunities for Impact of Community-Based Pharmacist-Led Biometric Health Screenings on ASCVD Risk
Similar Researchers
Based on overlapping research topics